| Breakdown | TTM | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 276.68M | 277.04M | 282.58M | 280.10M | 264.63M | 180.68M |
| Gross Profit | 51.00M | 53.75M | 51.82M | 43.90M | 55.03M | 19.95M |
| EBITDA | 39.41M | 36.59M | 33.96M | 38.21M | 39.13M | 32.13M |
| Net Income | 8.97M | 8.18M | 6.38M | 5.27M | 13.96M | -2.30M |
Balance Sheet | ||||||
| Total Assets | 149.51M | 126.95M | 118.81M | 137.26M | 149.33M | 180.44M |
| Cash, Cash Equivalents and Short-Term Investments | 3.71M | 4.12M | 1.62M | 10.20M | 16.28M | 8.31M |
| Total Debt | 146.49M | 74.93M | 77.76M | 98.22M | 111.14M | 143.01M |
| Total Liabilities | 136.99M | 111.11M | 108.73M | 135.60M | 148.95M | 171.62M |
| Stockholders Equity | 12.52M | 15.84M | 10.09M | 1.65M | 378.00K | 8.83M |
Cash Flow | ||||||
| Free Cash Flow | 28.64M | 27.60M | 17.87M | 20.61M | 45.33M | 27.73M |
| Operating Cash Flow | 34.70M | 33.48M | 25.16M | 29.22M | 49.16M | 30.13M |
| Investing Cash Flow | -6.43M | -5.00M | -5.83M | -6.45M | -2.94M | -2.38M |
| Financing Cash Flow | -24.43M | -25.53M | -27.21M | -29.42M | -38.13M | -22.59M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £39.77M | -3.95 | 15.03% | ― | 16.66% | 147.92% | |
67 Neutral | £228.28M | 16.03 | 12.51% | 7.08% | 6.18% | 4.22% | |
65 Neutral | £1.70B | 6.72 | 121.78% | 3.99% | 3.78% | 3.29% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | £26.59M | -1.20 | 63.25% | ― | -1.96% | 28.69% | |
56 Neutral | £664.75M | 8.84 | -113.93% | 1.40% | 3.94% | ― | |
46 Neutral | £761.06M | -2.16 | -62.07% | 4.48% | -19.03% | -318.35% |